Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,073 total articles
Quoin Pharmaceuticals announced that Japan’s Ministry of Health, Labour and Welfare granted Orphan Drug Designation to their drug candidate QRX003 for Netherton Syndrome, a rare genetic skin disorder with no approved treatments. This designation offers development incentives including market exclusivity, building on previous orphan and fast track d…
CPI Aerostructures announced a life-of-program supply agreement with Embraer to manufacture engine inlet assemblies for the Embraer Phenom 100EX business jets, expanding on their existing work with the Phenom 300E series. The agreement highlights CPI Aero's continued leadership in aerospace aerostructures and adds to their substantial backlog.
Satellogic, Inc., a U.S.-listed company specializing in satellite-based Persistent Global Intelligence, announced the appointment of retired U.S. Army Lieutenant General Michael E. Williamson as an independent director. Williamson brings extensive leadership experience in defense acquisition and aerospace, enhancing the company's capabilities as it…
Fate Therapeutics showcased data for its off-the-shelf CAR T-cell therapies FT819 and FT839 targeting autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis at the 2026 European Congress of Rheumatology. FT819 demonstrated rapid and sustained clinical improvements with a favorable safety profile and successful outpa…
Teva Pharmaceutical Industries Ltd. has begun launching AHZANTIVE®, an EMA-approved biosimilar to Eylea® (aflibercept), across multiple European countries. This launch broadens Teva's biosimilar portfolio, strengthens its presence in ophthalmology, and supports its Pivot to Growth strategy by improving patient access to biologic medicines for retin…
High Roller Technologies, Inc. announced the launch of its new prediction markets brand, ROLR, paired with a $25 million free-to-trade prediction challenge. The eight-week competition rewards traders weekly with cash prizes and culminates in a grand prize of $25 million. This initiative precedes the official launch of ROLR’s prediction markets prod…
Vivakor, Inc. has secured a one-year recurring crude oil transaction through its trading platform, covering approximately 100,000 barrels per month at the Cushing Terminal. This deal is estimated to generate about $108 million in annualized revenue, reinforcing the company's strategy of integrating crude oil marketing with its midstream infrastruct…
Trident Digital Tech Holdings Ltd., a Nasdaq-listed Singapore-headquartered digital infrastructure company, announced the launch of TDTHAI Africa, an AI-driven platform aiming to capitalize on digital infrastructure opportunities in Africa. Building on their Ghana deployment serving over 530,000 MSMEs with projected revenues of $800 million over fi…
Nexera Technologies Ltd announced that its majority-owned subsidiary, Fort Technology Inc., has received formal Nasdaq approval to list its common shares on the Nasdaq Capital Market under the ticker symbol "FRTT." Fort Technology's shares will continue trading on the TSX Venture Exchange. Nexera holds approximately 70.94% equity in Fort Technology…
Octave Intelligence plc has filed its Form 10-Q for the quarterly period ended March 31, 2026, with the U.S. Securities and Exchange Commission. This filing covers a period prior to the company’s public listing. Moving forward, Octave plans to announce quarterly results through press releases summarizing the highlights of its filings. Octave specia…
MACOM Technology Solutions Inc. announced a new portfolio of high-performance RF solutions designed to meet stringent aerospace and defense requirements. These include high-power amplifiers and front-end modules across S-Band, C-Band, X-Band, and wideband frequencies, incorporating GaN and GaAs technologies to enhance radar, communications, and ele…
Xos, Inc., a US-based leader in electric commercial vehicles and energy storage systems, has announced a registered direct offering of approximately 1.1 million shares of common stock at $5.50 per share, intending to raise about $6 million in gross proceeds. The company plans to use the funds to expand its Power Hub and energy storage business targ…
Emergent BioSolutions Inc. supports National Naloxone Awareness Day through partnership with Victoria's Voice Foundation to promote opioid overdose education and expand access to NARCAN® Nasal Spray and KLOXXADO® Nasal Spray. The company highlights new initiatives including the NARCAN® Nasal Spray Carrying Case and upcoming outreach in colleges to …
Provident Bank announced the promotion of Annamaria Vitelli to Executive Vice President, Chief Wealth Officer of Provident Bank, and President of its wealth management subsidiary, Beacon Trust. Vitelli will lead strategic growth initiatives across Provident's wealth management business, collaborating with business divisions to enhance integrated fi…
Immutep Limited announced positive interim Phase I clinical trial results for IMP761, a first-in-class LAG-3 agonist antibody targeting autoimmune diseases. The single ascending dose study demonstrated favorable safety, tolerability, and significant pharmacodynamic activity at 7 mg/kg in healthy volunteers. These findings support further clinical d…
Arvinas, Inc. announced its participation in the Michael J. Fox Foundation-supported LRRK2 Investigative Therapeutics Exchange (LITE) and Parkinson’s Precision Medicine Initiative (PPMI) programs. This collaboration aims to advance ARV-102, an investigational PROTAC drug targeting LRRK2 for treating Parkinson’s disease and related neurodegenerative…
Diginex Limited announced an expansion of its supply chain product suite with Risk-to-Remedy, an integrated solution for supply chain transparency and labor rights compliance, designed to help businesses comply with tightening global human rights regulations. The enhancement combines technology for risk assessment, worker engagement, and grievance …
IMUNON, Inc. announced a structured financing deal raising up to $10 million to fund enrollment in its pivotal Phase 3 OVATION 3 trial of IMNN-001, a DNA-mediated immunotherapy for advanced ovarian cancer. The financing combines preferred stock issuance and secured promissory notes with favorable terms intended to minimize dilution. Recent Phase 2 …
LanzaTech Global, Inc. announced the IPO of its joint venture, Beijing Shougang LanzaTech Technology Co., Ltd., on the Hong Kong Stock Exchange. The JV raised approximately $75 million, achieving a market capitalization of around $750 million. LanzaTech retained an 8.38% stake post-IPO. The listing demonstrates commercial viability of LanzaTech's c…
VCI Global Limited (NASDAQ: VCIG) provided a strategic business update highlighting its expanding institutional investor base, which includes prominent players in digital assets and blockchain technology. The company is actively pursuing growth opportunities across artificial intelligence infrastructure, digital assets, real-world assets, and capit…
Amneal Pharmaceuticals announced FDA approval of its romidepsin injection solution, a ready-to-use formulation that simplifies hospital and pharmacy preparation compared to the previously marketed lyophilized powder. The product’s Competitive Generic Therapy designation grants Amneal 180 days of market exclusivity, enhancing its differentiated inje…
NextCure, Inc. announced the availability of a replay for its virtual Key Opinion Leader event discussing the first clinical efficacy data from the Phase 1 dose escalation study of SIM0505, an investigational antibody-drug conjugate targeting Cadherin-6, for ovarian and uterine serous carcinoma cancers. The event featured experts from leading cance…
ChronoScale Corporation announced the appointments of Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to accelerate the company's AI infrastructure platform growth and global compute solutions delivery. These leadership additions aim to strengthen innovation and scale operations to meet rising enterprise demand…
ARS Pharmaceuticals has announced a collaboration with former NFL star Drew Brees to raise awareness about severe food allergies and the importance of preparedness using neffy®, an FDA-approved needle-free epinephrine nasal spray. This partnership aims to educate patients and caregivers on prompt treatment of severe allergic reactions to prevent an…
Celularity Inc. and Fountain Life announce the availability of cenplacel-L, a placental-derived allogeneic cell therapy, for investigational use by licensed physicians in Florida under recently enacted state legislation. This new regulatory framework allows use of certain cell therapies without FDA approval, enabling physician-directed application …
